Antigenic determinants in IgM paraprotein-related neuropathies

Research output: Contribution to journalArticlepeer-review


The association of neuropathy with IgM paraprotein has been known for several years, but only recently the pathogenetic relevance of this association has been clarified. Reactivity of the paraprotein with several neural antigens has been reported even if their pathogenetic relevance is not always clear. IgM binding to the Myelin-associated glycoprotein (MAG) is associated with a homogeneous demyelinating neuropathy, deposits of the paraprotein and complement on nerve myelin, and improvement concomitantly to anti-MAG IgM reduction. In particular, treatment with rituximab durably improved the neuropathy in two thirds of the patients, particularly those with moderately increased anti-MAG titres, which might be more easily reduced by this treatment. Several other IgM reactivities with nerve antigens have been reported in these patients, including several gangliosides and sulfatide even if, with the only exceptions of anti-sulfatide and anti-GQ1b ganglioside reactivities, their possible pathogenetic relevance remains to be established.

Original languageEnglish
Pages (from-to)107-109
Number of pages3
JournalClinical Lymphoma and Myeloma
Issue number1
Publication statusPublished - 2009


  • Monoclonal gammopathy of undetermined significance
  • Neuropathy
  • Waldenström
  • Waldenström's macroglobulinemia

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology


Dive into the research topics of 'Antigenic determinants in IgM paraprotein-related neuropathies'. Together they form a unique fingerprint.

Cite this